Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Dextromethorphan-Bupropion on Striatal Activity in Adults With Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the dextromethorphan–bupropion combination for major depressive disorder, currently recruiting to assess striatal brain activi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextromethorphan (dextromethorphan)
  • bupropion (bupropion)

Snippet

Sponsor: Roger McIntyre | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: RECRUITING